Blockchain Registration Transaction Record

Pancreatic Cancer Hijacks Blood Clotting to Evade Immune System

Mount Sinai study reveals pancreatic cancer evades immune system via blood clotting. Targeting this may boost immunotherapy. Read more on TechMediaWire.

This discovery matters because pancreatic cancer’s ability to evade the immune system has long been a major barrier to effective treatment. By identifying the blood clotting system as a key player in this evasion, researchers have opened a promising new target for immunotherapy. If therapies can disrupt this mechanism, they could make existing immunotherapies more effective and potentially improve survival rates for one of the most lethal cancers. The implications extend beyond pancreatic cancer, as other cancers may use similar wound-healing mechanisms to escape immune detection. Patients and investors alike should watch for further developments, as companies like Calidi Biotherapeutics and others may translate these findings into novel treatments, offering new hope where few options currently exist.